| Trial | EXCALIBER |
|---|---|
| Cancer Type | Haematological Cancers and Myeloma |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase 3, Two-Stage, Randomized, Multicenter, Open-Label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) |